Sign In

Login

Password

Forgot Password ? Sign Up

Toreforant (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Toreforant" in English language version.

refsWebsite
Global rank English rank
7nih.gov
4th place
4th place
6doi.org
2nd place
2nd place
2semanticscholar.org
11th place
8th place

doi.org (Global: 2nd place; English: 2nd place)

  • Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP (2017). "Clinical Development of Histamine H4 Receptor Antagonists". Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology. Vol. 241. pp. 301–320. doi:10.1007/164_2016_130. ISBN 978-3-319-58192-7. PMID 28233185.
  • Kollmeier AP, Barnathan ES, O'Brien C, Chen B, Xia Y, Zhou B, Loza MJ, Silkoff PE, Ge M, Thurmond RL (2018). "A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma". Annals of Allergy, Asthma & Immunology. 121 (5): 568–574. doi:10.1016/j.anai.2018.08.001. PMID 30102965. S2CID 51972933.
  • Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS (September 2016). "Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies". The Journal of Rheumatology. 43 (9): 1637–1642. doi:10.3899/jrheum.160164. PMID 27422891. S2CID 46885520.
  • Saravanan C, Bharti SK, Jaggi S, Singh SK (February 2011). "Histamine H4 receptor: a novel target for inflammation therapy". Mini Reviews in Medicinal Chemistry. 11 (2): 143–58. doi:10.2174/138955711794519519. PMID 21222579.
  • Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP (2017). "Clinical Development of Histamine H4 Receptor Antagonists". Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology. Vol. 241. pp. 301–320. doi:10.1007/164_2016_130. ISBN 978-3-319-58192-7. PMID 28233185.
  • Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, et al. (2018). "The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets". Frontiers in Immunology. 9 1873. doi:10.3389/fimmu.2018.01873. PMC 6099187. PMID 30150993.

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

  • Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP (2017). "Clinical Development of Histamine H4 Receptor Antagonists". Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology. Vol. 241. pp. 301–320. doi:10.1007/164_2016_130. ISBN 978-3-319-58192-7. PMID 28233185.
  • Kollmeier AP, Barnathan ES, O'Brien C, Chen B, Xia Y, Zhou B, Loza MJ, Silkoff PE, Ge M, Thurmond RL (2018). "A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma". Annals of Allergy, Asthma & Immunology. 121 (5): 568–574. doi:10.1016/j.anai.2018.08.001. PMID 30102965. S2CID 51972933.
  • Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS (September 2016). "Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies". The Journal of Rheumatology. 43 (9): 1637–1642. doi:10.3899/jrheum.160164. PMID 27422891. S2CID 46885520.
  • Saravanan C, Bharti SK, Jaggi S, Singh SK (February 2011). "Histamine H4 receptor: a novel target for inflammation therapy". Mini Reviews in Medicinal Chemistry. 11 (2): 143–58. doi:10.2174/138955711794519519. PMID 21222579.
  • Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP (2017). "Clinical Development of Histamine H4 Receptor Antagonists". Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology. Vol. 241. pp. 301–320. doi:10.1007/164_2016_130. ISBN 978-3-319-58192-7. PMID 28233185.
  • Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, et al. (2018). "The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets". Frontiers in Immunology. 9 1873. doi:10.3389/fimmu.2018.01873. PMC 6099187. PMID 30150993.

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

  • Kollmeier AP, Barnathan ES, O'Brien C, Chen B, Xia Y, Zhou B, Loza MJ, Silkoff PE, Ge M, Thurmond RL (2018). "A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma". Annals of Allergy, Asthma & Immunology. 121 (5): 568–574. doi:10.1016/j.anai.2018.08.001. PMID 30102965. S2CID 51972933.
  • Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS (September 2016). "Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies". The Journal of Rheumatology. 43 (9): 1637–1642. doi:10.3899/jrheum.160164. PMID 27422891. S2CID 46885520.